{"id":26023,"date":"2017-03-14T14:26:00","date_gmt":"2017-03-14T18:26:00","guid":{"rendered":"https:\/\/www.cancerresearch.org\/blog\/marzo-2017\/ann-s"},"modified":"2022-10-13T07:38:37","modified_gmt":"2022-10-13T11:38:37","slug":"ann-s","status":"publish","type":"post","link":"https:\/\/www.cancerresearch.org\/es\/blog\/ann-s","title":{"rendered":"Ann Silberman&#8217;s Immunotherapy Story"},"content":{"rendered":"\n<p><strong>C\u00e1ncer de mama | 2009<\/strong><\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>Se aprende a ver la vida de otra manera cuando se sabe que es probable que sea muy corta. Por un lado es dif\u00edcil, pero tambi\u00e9n es hermoso&#8230;<\/p><\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\">La historia de Ann<\/h2>\n\n\n\n<p>Ann S padece c\u00e1ncer de mama metast\u00e1sico y est\u00e1 en remisi\u00f3n gracias al Herceptin y al Perjeta.<\/p>\n\n\n\n<p>En 2009, se le diagnostic\u00f3 c\u00e1ncer de mama HER2 positivo en estadio II y se la trat\u00f3 con cirug\u00eda, quimioterapia y el anticuerpo monoclonal Herceptin\u00ae (trastuzumab), un tipo de inmunoterapia. Cuando el c\u00e1ncer reapareci\u00f3 en 2011, era de estadio IV.<br><br>Empez\u00f3 un tratamiento dif\u00edcil que incluy\u00f3 cirug\u00eda, radioterapia y varios tipos de quimioterapia, hasta que, al final, comenz\u00f3 con una combinaci\u00f3n de Herceptin y un segundo anticuerpo monoclonal: Perjeta\u00ae (pertuzumab). La combinaci\u00f3n de estas dos inmunoterapias desaceler\u00f3 y luego detuvo el crecimiento del c\u00e1ncer, y por m\u00e1s de un a\u00f1o estuvo en remisi\u00f3n completa. Actualmente recibe Kadcyla\u00ae y un conjugado de anticuerpos.<br><br>Ann es defensora de pacientes con c\u00e1ncer de mama y escribe en el blog&nbsp;<a href=\"https:\/\/www.butdoctorihatepink.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">\u00bfC\u00e1ncer de mama? Pero, doctor, \u00a1odio el rosado!<\/a>&nbsp;Hace poco, habl\u00f3 en una conferencia de SXSW sobre su experiencia como paciente con c\u00e1ncer de mama.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Questions and Answers<\/h2>\n\n\n\n\n<p>I was diagnosed with breast cancer in 2009. I was 51 years old and my youngest son (I have two boys) was 12. Because I was HER2 positive, I did chemo and a year of Herceptin. I was finished with my treatment in December of 2010 and started on the hormonal therapy tamoxifen (Nolvadex). The following May, we discovered that cancer had returned, and was in my liver. I was Stage 4.<\/p>\n\n\n\n<p>Having a diagnosis that\u2019s considered life-ending, I struggled to adjust, but amazingly, I did. You learn to see life in a different way when you know it is likely to be very short. Some of it is difficult. But some of it is beautiful, as you are able to make sure to say all the things you need to say to the people you love, and to really plan for your death.<\/p>\n\n\n\n\n\n<p>After about four years of chemo, I was not tolerating it well. My white cell count was always critically low. Yet, cancer was still only in my liver and never spread anywhere else, which was a hopeful sign. My oncologist thought we might try Stereotactic Body Radiation Therapy, or SBRT. At the same time, Perjeta was approved by the FDA, so he started me on that along with Herceptin and the chemotherapy Gemzar\u00ae (gemcitabine).<\/p>\n\n\n\n\n\n<p>For a year my cancer was stable on the immunotherapy combo. The second year, my scan showed that I was in full remission, due to what I call \u201cThe Wonder Drug,\u201d Perjeta. It\u2019s easy to take, has minimal side effects, and it has made my cancer disappear.<\/p>\n\n\n\n\n\n<p>When I was diagnosed, Perjeta was not in existence. After years of treatment, I was becoming critically ill, sleeping days at a time, unable to leave the house, susceptible to infection. I could easily see that I didn\u2019t have much time left. Then Perjeta became available and reopened a door had been closed.<\/p>\n\n\n\n<p>I am not special. I have no powers. I didn\u2019t change any habits &#8212; I eat the same, exercise the same. Medical science has a few tricks up its sleeves, and it is possible you will be the beneficiary. &nbsp;<\/p>\n\n\n\n\n\n<p>You never know what is being worked on and will be approved in time for you. Don\u2019t give up hope until you have to. (I\u2019m not one to tell somebody to never give up because there comes a time when many cancer patients must accept the inevitable.)<\/p>\n\n\n\n\n\n<p>My advice is to get a good doctor who is up on the latest, keep your appointments, stay on top of what is happening in the field of your type of cancer, try everything that is offered, and hope for the best. I never thought I\u2019d not only be here today, but also be healthy. I am very grateful.&nbsp; &nbsp;<br><br>When I was first diagnosed with metastatic breast cancer, my goal was to see my son graduate high school. I made that goal, and that was one of the most beautiful days of my life.<\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>C\u00e1ncer de mama | 2009 Se aprende a ver la vida de otra manera cuando se sabe que es probable que sea muy corta. Por un lado es dif\u00edcil, pero tambi\u00e9n es [&hellip;]<\/p>\n","protected":false},"author":22,"featured_media":21971,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[377],"tags":[680,439],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-26023","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar","tag-breast-cancer-es","tag-patient-stories-es"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ann Silberman&#039;s Immunotherapy Story - Cancer Research Institute<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/blog\/ann-s\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ann Silberman&#039;s Immunotherapy Story - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"C\u00e1ncer de mama | 2009 Se aprende a ver la vida de otra manera cuando se sabe que es probable que sea muy corta. Por un lado es dif\u00edcil, pero tambi\u00e9n es [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/blog\/ann-s\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:published_time\" content=\"2017-03-14T18:26:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-13T11:38:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/Ann-S-teaser-image-620-x-358.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t<meta property=\"og:image:height\" content=\"358\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"CRI Staff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"CRI Staff\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/ann-s#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/ann-s\"},\"author\":{\"name\":\"CRI Staff\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/person\/680495be68bab0b66f6ed175092684d4\"},\"headline\":\"Ann Silberman&#8217;s Immunotherapy Story\",\"datePublished\":\"2017-03-14T18:26:00+00:00\",\"dateModified\":\"2022-10-13T11:38:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/ann-s\"},\"wordCount\":724,\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/ann-s#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/Ann-S-teaser-image-620-x-358.jpg\",\"keywords\":[\"breast cancer\",\"patient stories\"],\"articleSection\":[\"Sin categorizar\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/ann-s\",\"url\":\"https:\/\/www.cancerresearch.org\/blog\/ann-s\",\"name\":\"Ann Silberman's Immunotherapy Story - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/ann-s#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/ann-s#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/Ann-S-teaser-image-620-x-358.jpg\",\"datePublished\":\"2017-03-14T18:26:00+00:00\",\"dateModified\":\"2022-10-13T11:38:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/ann-s#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/blog\/ann-s\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/ann-s#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/Ann-S-teaser-image-620-x-358.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/Ann-S-teaser-image-620-x-358.jpg\",\"width\":620,\"height\":358,\"caption\":\"Ann Silberman\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/ann-s#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ann Silberman&#8217;s Immunotherapy Story\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/person\/680495be68bab0b66f6ed175092684d4\",\"name\":\"CRI Staff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/02f0ef777fed64d4eb97f93e70b904a9061fb107f8ea80db798cc9417248410f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/02f0ef777fed64d4eb97f93e70b904a9061fb107f8ea80db798cc9417248410f?s=96&d=mm&r=g\",\"caption\":\"CRI Staff\"},\"url\":\"https:\/\/www.cancerresearch.org\/es\/blog\/author\/cristaff\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ann Silberman's Immunotherapy Story - Cancer Research Institute","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/blog\/ann-s","og_locale":"es_ES","og_type":"article","og_title":"Ann Silberman's Immunotherapy Story - Cancer Research Institute","og_description":"C\u00e1ncer de mama | 2009 Se aprende a ver la vida de otra manera cuando se sabe que es probable que sea muy corta. Por un lado es dif\u00edcil, pero tambi\u00e9n es [&hellip;]","og_url":"https:\/\/www.cancerresearch.org\/blog\/ann-s","og_site_name":"Cancer Research Institute","article_published_time":"2017-03-14T18:26:00+00:00","article_modified_time":"2022-10-13T11:38:37+00:00","og_image":[{"width":620,"height":358,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/Ann-S-teaser-image-620-x-358.jpg","type":"image\/jpeg"}],"author":"CRI Staff","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"CRI Staff","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cancerresearch.org\/blog\/ann-s#article","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/blog\/ann-s"},"author":{"name":"CRI Staff","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/person\/680495be68bab0b66f6ed175092684d4"},"headline":"Ann Silberman&#8217;s Immunotherapy Story","datePublished":"2017-03-14T18:26:00+00:00","dateModified":"2022-10-13T11:38:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cancerresearch.org\/blog\/ann-s"},"wordCount":724,"publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"image":{"@id":"https:\/\/www.cancerresearch.org\/blog\/ann-s#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/Ann-S-teaser-image-620-x-358.jpg","keywords":["breast cancer","patient stories"],"articleSection":["Sin categorizar"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/blog\/ann-s","url":"https:\/\/www.cancerresearch.org\/blog\/ann-s","name":"Ann Silberman's Immunotherapy Story - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/blog\/ann-s#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/blog\/ann-s#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/Ann-S-teaser-image-620-x-358.jpg","datePublished":"2017-03-14T18:26:00+00:00","dateModified":"2022-10-13T11:38:37+00:00","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/blog\/ann-s#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/blog\/ann-s"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/blog\/ann-s#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/Ann-S-teaser-image-620-x-358.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/Ann-S-teaser-image-620-x-358.jpg","width":620,"height":358,"caption":"Ann Silberman"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/blog\/ann-s#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Ann Silberman&#8217;s Immunotherapy Story"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/person\/680495be68bab0b66f6ed175092684d4","name":"CRI Staff","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/02f0ef777fed64d4eb97f93e70b904a9061fb107f8ea80db798cc9417248410f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/02f0ef777fed64d4eb97f93e70b904a9061fb107f8ea80db798cc9417248410f?s=96&d=mm&r=g","caption":"CRI Staff"},"url":"https:\/\/www.cancerresearch.org\/es\/blog\/author\/cristaff"}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/posts\/26023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/comments?post=26023"}],"version-history":[{"count":0,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/posts\/26023\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/21971"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=26023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/categories?post=26023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tags?post=26023"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=26023"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=26023"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=26023"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=26023"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=26023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}